英语释义

• when the patent protection for a brand-name drug expires generic versions of the drug can be offered for sale if the FDA agrees;

  "generic drugs are usually cheaper than brand-name drugs"

片语

Generic-named drug通用名药物

Generic drug names通用名药物

first generic drug复星医药的首仿药

generic drug name bactrim第二十一章

generic drug substitution仿制药替代

Generic Drug International Forum仿制药国际论坛

Primidone Generic Drug首页

generic drug superstars仿制药大品种

英汉例句

• it has expressed concern over generic drug firms increasingly settling patent lawsuits with large mncs.

  表示了对一般药品公司与大型跨国公司之间解决专利诉讼这个问题越来越多的关注。

• the deals behind the ftc crackdown have become increasingly common ever since congress opened the door for generic drug competition in 1984.

  这种被联邦贸易委员会所攻击的交易其实在1984年国会为仿制药生产商参与竞争打开方便之门后就变的越来越普遍了。

• teva pharmaceutical industries ltd, watson pharmaceuticals inc, mylan inc and other generic drug makers also sell the drug under its chemical name topiramate.

  teva制药工业有限公司股份有限公司，公司mylan华生药品和其他非专利药制定者也出售药品在化学名称托吡酯治疗。

• the deal makes abbott a key player in india「s generic drug market.

  亿美元。此次收购使雅培公司成为印度通用药物市场的主要企业。

• arv prices have dropped significantly and procurement systems have improved, as has generic drug availability.

  arv药物的价格已经明显下降，采购体制也得到了改善，生物药品的可获得性也有所改善。

• the current situation of generic drug management in china is analyzed by introducing the regulations of generic drug management of the recent 20 years of us government.

  介绍美国政府20多年来针对仿制药管理的主要法规，分析我国仿制药管理的现状。

• it is the lead drug candidate for opko, a miami start-up company run by phillip frost, the billionaire who founded the generic drug company ivax.

  它是opko候选的主打药物。opko是一家迈阿密公司，由建立了基因药物公司ivax的亿万富翁phillipfrost经营。

• the decisions are the latest in a string of legal victories for cipla, india」s largest generic drug maker.

  该决定是cipla公司的一连串法律胜利的最新一个成果。

• the new generics could also be a boon to generic drug manufacturers such as teva, barr, and mylan labs.

  新的仿制药同样会使仿制药生产商受益，如梯瓦、巴尔、麦兰医学实验室。

• that compared to 5.8 months for the women who got only paclitaxel, a generic drug also sold as the branded treatment taxol.

  这较单独应用紫杉醇的乳腺癌患者的5.8个月生存时间明显延长，紫杉醇是一种普通药，也常当成商品名紫杉酚卖。

• generic drug exclusivity is a unique form of administrative protection for pharmaceutical products in united states.

  仿制药独占制度是美国特有的一种药品行政保护形式。

• a generic drug product is one that is comparable to an innovator drug product in dosageform, strength, route of administration, quality, performance characteristics and intended use.

  仿制药在剂型，剂量，服用方式，质量，性能特征和用途方法都是和原创药物等同的。

• cliggott thinks generic drug maker teva pharmaceutical industries (teva) could benefit from any assault on drug pricing.

  克里哥特就认为通用药品制造商teva药业就能从任何对药品价格的攻击中获利。

• a generic drug can every now cost as less as 60 - 70% of the brand repute drug.

  一个非专利药可以每现在消耗少60- 70%的品牌声誉药物。

• as well, fda will increase its communications with generic drug manufacturers and provide training on proper application submission to the industry in meetings and webcasts.

  同时，fda将加强同仿制药生产商的沟通，将会通过会议和网络广播向企业界提供书写规范申请提交书的培训。

• generic drug application reviewers focus on bioequivalence data, chemistry and microbiology data, requests for plant inspection, and drug labeling information.

  仿制药申请的的评审官着重于生物等效性资料，化学和生物资料，工厂检查的要求和药品标签信息等。

• regardless of the outcome, the case raises an important legal question: how can a firm like apotex bring a generic drug to market when others own a perfectly valid patent for it?

  不管最后结果如何，该案例引发了一个重大的法律问题：象apotex这样的仿制药品怎么会闯入别人拥有完全有效专利认可的药品市场呢？

• a typical generic drug may cost a few million dollars to develop, he estimates, but a biosimilar version could cost perhaps $100m-150m.

  他估计一种具有代表性的非专利药品可能需要几百万美元就可以研发出来，而一种生物仿制药品的研发则可能会需要1亿到1亿5千万美元。

• the u. s. food and drug administration today outlined a program aimed at increasing the number and variety of generic drug products available to consumers and health care providers.

  今天，美国食品药品监督管理局宣布了一项计划，旨在增加仿制药的数量与种类，方便消费者和保健护理人员。

• suggestion for the improvement of the legalized management of chinese generic drug is made based on comparison.

  通过比较，提出了完善我国仿制药法制化管理的建议。

• generic drug dealers now have end of trade dialogue.

  通用毒贩现在有贸易对话结束。

• 「big pharma」 has long felt the competitive breath of generic drug companies.

  （这家）「大型制药公司」已经长期感到非专利药品公司的竞争压力。

• in 2007, brazil sidestepped a patent on merck & co inc's aids drug efavirenz to import a cheaper generic drug from india.

  2007年，巴西曾绕开了默克公司的抗艾药物依非韦侖的专利，转而从印度进口了一种较为廉价的非专利药物。

• developing our own generic drug superstars is one of the ways to vitalize our national pharmaceutical industry.

  培养仿制药大品种是振兴民族制药企业的可行途径之一。

• generic drug manufacturers must demonstrate that a generic drug has the same dosage form, strength, route of administration, and conditions of use as the approved brand-name product.

  仿制药生产商必须保证仿制药与已审批的品牌药有相同的剂型、成分、适应癥和使用范围。